GlassScriptPhysician profile
Jason C Rowling
NPI 1639259690
$8,167.62
in general payments reported to CMS, 2019-2025
21 companies · $3,588 in 2025
The $3,588 reported for 2025 was more than what 98% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $823 · 2020: $210 · 2021: $590 · 2022: $816 · 2023: $1,635 · 2024: $505 · 2025: $3,588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,452 · Food and Beverage: $2,276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,452.28 |
| Food and Beverage | $2,275.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,433.16 | 2019-2025 | General - Therapies, Wavewriter Alpha Prime 16, General - Pain Management |
| Abbott Laboratories | $1,255.56 | 2019-2024 | Proclaim, Eterna |
| Medtronic, INC. | $393.81 | 2023-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Nevro Corp. | $267.66 | 2019-2023 | Senza |
| Medtronic USA, INC. | $199.50 | 2019 | |
| Pfizer INC. | $110.00 | 2019 | |
| Globus Medical, INC. | $91.97 | 2025 | Senza |
| Spr Therapeutics, INC | $58.06 | 2022-2025 | Sprint Pns System |
| Tersera Therapeutics LLC | $47.56 | 2019 | |
| Collegium Pharmaceutical, INC. | $46.90 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.22 | 2019 | |
| Forte Bio-Pharma LLC | $36.01 | 2019 | |
| Saluda Medical Americas, INC. | $32.32 | 2025 | Evoke |
| Stryker Corporation | $26.78 | 2019 | |
| Relievant Medsystems, INC. | $26.13 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $24.48 | 2019 | |
| Biodelivery Sciences International, INC. | $23.72 | 2019 | |
| Pacira Therapeutics, INC. | $18.03 | 2019 | |
| Nalu Medical, INC. | $14.13 | 2023 | Nalu Neurostimulation System |
| Assertio Therapeutics, INC. | $12.89 | 2019 | |
| Scilex Pharmaceuticals INC. | $11.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Rowling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.